Atlas Trials

ProQR Therapeutics

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ProQR Therapeutics

RecordFirmDate
Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3 (NCT05052554)ProQR Therapeutics2021-08-10
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. (NCT04855045)ProQR Therapeutics2021-03-23
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene (NCT04123626)ProQR Therapeutics2019-10-07
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) (NCT03913143)ProQR Therapeutics2019-04-04
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (NCT03780257)ProQR Therapeutics2019-03-06

Track ProQR Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.